McMahon L R, Cunningham K A
Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77555-1031, USA.
J Pharmacol Exp Ther. 2001 Apr;297(1):357-63.
Serotonin (5-hydroxytryptamine; 5-HT) 5-HT(2A) receptors have been shown to modulate dopamine (DA) function and a more thorough appreciation of this modulatory interaction between 5-HT2A receptors and DA systems may yield insight into novel approaches to treatment of cocaine dependence. The present study examined the effects of two ligands with varying selectivity for 5-HT2A receptors on the locomotor stimulant and discriminative stimulus effects of cocaine in male rats. Locomotor activity was measured following intraperitoneal injection of vehicle (1 ml/kg), the selective 5-HT2A receptor antagonist M100907 [R-(+)-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidine-methanol] (0.02-2.0 mg/kg), or the 5-HT(2) receptor antagonist ketanserin (0.04-4 mg/kg) 45 min before administration of saline (1 ml/kg) or cocaine (10 mg/kg); monitoring of activity in photobeam chambers began at once and proceeded for 1 h. Neither M100907 nor ketanserin significantly altered basal locomotor activity, but both drugs attenuated cocaine-induced hyperactivity (p < 0.05). In drug discrimination studies, rats were trained to discriminate cocaine (10 mg/kg) from saline (1 ml/kg) in a two-lever, water-reinforced operant task. M100907 (0.05-1.6 mg/kg) and ketanserin (0.05-4 mg/kg) evoked a dose-related attenuation of the stimulus effects of cocaine (5 mg/kg, p < 0.05). These results suggest that 5-HT2A receptors play an important role in the behavioral effects of cocaine and that 5-HT2A receptors should be considered a viable target for analysis in the search for pharmacotherapies useful in the treatment of cocaine dependence.
血清素(5-羟色胺;5-HT)5-HT(2A)受体已被证明可调节多巴胺(DA)功能,更深入地了解5-HT2A受体与DA系统之间的这种调节相互作用,可能会为治疗可卡因成瘾提供新的方法。本研究考察了两种对5-HT2A受体具有不同选择性的配体,对雄性大鼠中可卡因的运动兴奋和辨别刺激作用的影响。腹腔注射溶剂(1毫升/千克)、选择性5-HT2A受体拮抗剂M100907 [R-(+)-(2,3-二甲氧基苯基)-1-[2-(4-氟苯乙基)]-4-哌啶甲醇](0.02 - 2.0毫克/千克)或5-HT(2)受体拮抗剂酮色林(0.04 - 4毫克/千克)45分钟后,再给予生理盐水(1毫升/千克)或可卡因(10毫克/千克),然后测量运动活性;在光控室中对活性的监测立即开始并持续1小时。M100907和酮色林均未显著改变基础运动活性,但两种药物均减弱了可卡因诱导的多动(p < 0.05)。在药物辨别研究中,大鼠在双杠杆、水强化操作性任务中接受训练,以区分可卡因(10毫克/千克)和生理盐水(1毫升/千克)。M100907(0.05 - 1.6毫克/千克)和酮色林(0.05 - 4毫克/千克)引起可卡因刺激作用的剂量相关减弱(5毫克/千克,p < 0.05)。这些结果表明,5-HT2A受体在可卡因的行为效应中起重要作用,并且在寻找可用于治疗可卡因成瘾的药物疗法时,5-HT2A受体应被视为一个可行的分析靶点。